The stock market experienced an uptick on Monday as progress was made by lawmakers toward reaching an agreement that could potentially end the historic government shutdown. Jim Cramer, during the CNBC Investing Club’s “Morning Meeting,” described the shutdown as a “confidence killer,” referencing last week’s consumer sentiment figures that approached record lows. Cramer emphasized the urgency of reopening the government, believing it would significantly boost consumer morale, particularly if travel disruptions are resolved in time for the holiday season. He noted, “It’s going to help consumer spend,” and expressed an optimistic outlook for consumer behavior subsequently.
In the realm of artificial intelligence, Nvidia saw a positive rebound with share prices climbing nearly 4% after experiencing a 7% dip the previous week. Citi initiated a positive catalyst watch on the tech giant and raised its price target from $210 to $220, anticipating a strong earnings report when Nvidia releases its results next Wednesday. Analysts highlighted several key points to be addressed during the call, including the sustainability of AI-related capital expenditures by Nvidia’s customers. Attention will also be given to CEO Jensen Huang’s prior remarks about China’s position in the AI landscape, which he later refined.
Eli Lilly also had a strong showing, with shares rising close to 5% after Leerink upgraded the stock from a hold to a buy-equivalent rating and increased its price target from $886 to $1,104. Analysts praised the pharmaceutical company’s recent GLP-1 pricing agreement with the Trump administration. Given expectations for increased adoption of obesity treatments driven by expanded Medicare and Medicaid access by 2027, it appears that momentum is firmly on Lilly’s side. Following a previous downgrade in August after lackluster earnings, Cramer deemed that decision a “big mistake.” He mentioned that the company is nearing a $1 trillion market cap and indicated that the Club might consider trimming their holdings, stating, “Once again, it’s a parabolic move, and we sell parabolas.” Cramer contrasted Eli Lilly’s position favorably against competitors such as Novo Nordisk.
During a rapid-fire segment of the meeting, Cramer also discussed stocks such as Pfizer, Tyson, monday.com, and MP Materials, reinforcing his strategic focus. For members of the CNBC Investing Club, alerts regarding trades will be provided before any executions occur, with specific waiting periods applied depending on the nature of the announcement.
This summary reflects the highlights from the latest meeting, emphasizing stock performance and market outlook amid critical developments on various fronts.
